{
    "code": "60000991",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60000991",
    "time": "2023-05-25 21:51:15",
    "許可證字號": "衛部菌疫輸字第000991號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/08\/26",
    "發證\/登錄日期": "104\/08\/26",
    "許可證\/登錄種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA06000099105",
    "中文品名": "可善挺注射液劑150毫克\/毫升",
    "英文品名": "Cosentyx 150mg\/ml Solution for Injection",
    "適應症": "1.斑塊性乾癬：適用於治療適合接受全身性治療的中至重度斑塊性乾癬6歲以上病人。\r\n2.乾癬性關節炎：適用於治療患有活動性乾癬性關節炎的成人病人。可單獨使用或與methotrexate併用。\r\n3.中軸性脊椎關節炎(Axial spondyloarthritis, asSpA)\r\n   (1)僵直性脊椎炎(Ankylosing spondylitis, AS)：治療活動性僵直性脊椎炎成人病人。\r\n   (2)\t無放射影像確認之中軸性脊椎關節炎(Non-radiographic axial spondyloarthritis，簡稱nr-axSpA)：適用於治療嚴重活動性無放射影像確認之中軸性脊椎關節炎且符合下列所有條件的成人病人：\r\n    甲、對非類固醇抗發炎藥物(NSAID)治療反應不佳或無法耐受。\r\n    乙、其C反應蛋白(C-reactive protein，簡稱CRP)濃度升高。\r\n    丙、核磁共振造影(MRI)檢查證據顯示有發炎的客觀跡象。\r\n    丁、HLA-B27陽性。\r\n4.\t兒童特發性關節炎(Juvenile Idiopathic Arthritis, JIA)\r\n   (1)\t接骨點發炎相關型關節炎(Enthesitis-Related Arthritis, ERA)：適用於6歲以上兒童，以治療經標準治療反應不佳或無法耐受之活動性接骨點發炎相關型關節炎。\r\n   (2)\t兒童乾癬性關節炎(Juvenile Psoriatic Arthritis, JPsA)：適用於6歲以上兒童，以治療經標準治療反應不佳或無法耐受之活動性兒童乾癬性關節炎。",
    "劑型": "27D注射液劑",
    "包裝": "100支以下盒裝 1毫升注射筆裝 2毫升注射筆裝 0.5毫升玻璃注射針筒裝 1毫升玻璃注射針筒裝 2毫升玻璃注射針筒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "109\/08\/26",
    "主成分略述": "Secukinumab",
    "限制項目": "02輸　入 51免除銜接性臨床試驗",
    "申請商名稱": "台灣諾華股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號8樓",
    "主製造廠": [
        {
            "製造廠名稱": "NOVARTIS PHARMA STEIN AG",
            "製造廠廠址": "SCHAFFHAUSERSTRASSE CH-4332 STEIN, SWITZERLAND",
            "製造廠公司地址": "CH-4002,BASEL,SWITZERLAND",
            "製造廠國別": "SWITZERLAND",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "SANDOZ GMBH,  SCHAFTENAU PLANT",
            "製造廠廠址": "BIOCHEMIESTRASSE 10, A6336 LANGKAMPFEN, AUSTRIA",
            "製造廠公司地址": "",
            "製造廠國別": "AUSTRIA",
            "製程": "成品製造、一級包裝、二級包裝"
        },
        {
            "製造廠名稱": "NOVARTIS PHARMA. AG",
            "製造廠廠址": "LICHTSTRASSE 35, 4056 BASEL, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "許可證持有者"
        },
        {
            "製造廠名稱": "NOVARTIS PHARMA S.A.S.",
            "製造廠廠址": "8, RUE DE L&#39;INDUSTRIE, F-68330 HUNINGUE, FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "Sandoz GmbH",
            "製造廠廠址": "BIOCHEMIESTRASSE 10, 6336 LANGKAMPFEN, AUSTRIA",
            "製造廠公司地址": "",
            "製造廠國別": "AUSTRIA",
            "製程": "原料藥製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200090100",
            "成分名稱": "Secukinumab",
            "含量描述": "",
            "含量": "150.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "000991_Cosentyx 150mgml Solution for Injection_1-108-06-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000991&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Cosentyx Solution_TWI-120522_2021-PSB.GLC-1251-s (完稿)-111-05-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000991&Seq=017&Type=9"
        },
        {
            "title": "750621-Cosentyx inj-FB-109-02-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000991&Seq=009&Type=8"
        },
        {
            "title": "可善挺注射液劑-標籤3-107-10-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000991&Seq=008&Type=8"
        },
        {
            "title": "可善挺注射液劑-標籤2-107-10-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000991&Seq=007&Type=8"
        },
        {
            "title": "可善挺注射液劑-標籤1-107-10-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000991&Seq=006&Type=8"
        },
        {
            "title": "可善挺注射液劑-外盒-107-10-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000991&Seq=005&Type=8"
        }
    ]
}